Earnings History Data for Amarin Corporation plc (AMRN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Amarin Corporation plc

Amarin Corporation plc is a global pharmaceutical group which develops innovative pharmaceutical products across a range of therapeutic areas utilizing its proprietary advanced oral and transdermal drug delivery technologies.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
05-08-2021	PM	6:10 AM ET (Aug 5)	AMRN	Amarin Corporation plc	1,630	0.02	-0.04	0.01	Amarin EPS beats by $0.06, beats on revenue [8/5/2021 6:03 AM]	4.84	0.41 (9.12%)	4.53	0.09 (2.03%)	3.36 - 9.25	9,647,736	3,180,000	98,043
Amarin Q2 2021 Earnings Preview [8/4/2021 1:25 PM] Amarin EPS beats by $0.06, beats on revenue [8/5/2021 6:03 AM] Amarin posts Q2 earnings beat, provides cash position update [8/5/2021 7:58 AM] Amarin Reports Second Quarter and Six Month 2021 Financial Results and Provides Business Update [Aug-05-21 06:00AM] Amarin (AMRN) Q2 2021 Earnings Call Transcript [Aug-05-21 12:00PM] Why Amarin Is Soaring Today [Aug-05-21 02:34PM]
29-04-2021	PM	5:55 AM ET (Apr 29)	AMRN	Amarin Corporation plc	2,020	N/A	-0.05	-0.06	Amarin EPS beats by $0.07, misses on revenue [4/29/2021 6:16 AM]	5.24	0.05 (0.96%)	5.24	0.0 (0.00%)	3.36 - 9.25	6,228,084	4,540,000	3,027
Amarin Q1 2021 Earnings Preview [4/28/2021 1:06 PM] Amarin EPS beats by $0.07, misses on revenue [4/29/2021 6:16 AM] Amarin reports decline in Q1 revenue ahead of European launch of VAZKEPA [4/29/2021 7:31 AM] Amarin Announces Planned Retirement of Joseph T. Kennedy, EVP, General Counsel [Apr-29-21 06:00AM] Amarin Reports First Quarter 2021 Financial Results and Provides Business Update [Apr-29-21 06:10AM] Amarin (AMRN) Q1 Earnings Top, Vascepa Sales Hit by COVID-19 [Apr-29-21 12:00PM] Amarin (AMRN) Q1 2021 Earnings Call Transcript [Apr-29-21 08:01PM]
25-02-2021	PM	6:00 AM ET (Feb 25)	AMRN	Amarin Corporation plc	2,950	0.01	-0.01	0.02	Amarin EPS beats by $0.04, beats on revenue [2/25/2021 5:58 AM]	6.96	-0.34 (-4.66%)	7.47	0.17 (2.33%)	3.36 - 18.00	5,324,970	5,722,029	152,859
Amarin EPS beats by $0.04, beats on revenue [2/25/2021 5:58 AM] Amarin Q4 2020 Earnings Preview [2/24/2021 11:55 AM] Amarin Q4 results led by strong Vascepa sales [2/25/2021 9:48 AM] How Amarin Beat Wall Street's Q4 Estimates [Feb-25-21 11:21AM]
05-11-2020	PM	6:00 AM ET (Nov 5)	AMRN	Amarin Corporation plc	1,950	-0.02	0.01	-0.01	Amarin EPS in-line, beats on revenue [11/5/2020 6:01 AM]	4.51	-0.48 (-9.62%)	4.58	0.07 (1.55%)	3.36 - 26.12	10,625,317	3,207,379	4,250

04-08-2020	PM	5:00 AM ET (Aug 4)	AMRN	Amarin Corporation plc	2,500	0.01	-0.08	-0.01	Amarin EPS beats by $0.11, misses on revenue [8/4/2020 6:03 AM]	7.02	0.25 (3.69%)	6.53	-0.24 (-3.54%)	3.95 - 26.12	9,824,056	5,489,381	310,256